Real-world risk of new-onset inflammatory bowel disease among patients with psoriasis exposed to interleukin 17 inhibitors
Shari Wright, Allireza Alloo, Andrew Strunk, Amit Garg
Topics & Concepts
MedicinePsoriasisOdds ratioSecukinumabIncidence (geometry)Inflammatory bowel diseaseInternal medicineConfidence intervalCohort studyRetrospective cohort studyDermatologyDiseasePsoriatic arthritisOpticsPhysicsPsoriasis: Treatment and PathogenesisInflammatory Bowel DiseaseSpondyloarthritis Studies and Treatments